Abcam warns on revenues as Covid-19 hits markets
(Sharecast News) - Life sciences tools provider Abcam warned on full-year revenues on Monday as the Covid-19 pandemic began to take its toll across the group's markets.
Read moreWed, 18th Dec 2019 13:25
(Sharecast News) - Life sciences tools provider Abcam warned on full-year revenues on Monday as the Covid-19 pandemic began to take its toll across the group's markets.
Read moreUK BROKER RATINGS SUMMARY: HSBC Downgrades Prudential And Centrica
Read moreAbacam To Raise GBP110 Million Through Share Issue To Fund Growth
Read moreUK BROKER RATINGS SUMMARY: BHP Gets Upgrades From JPMorgan, Deutsche
Read moreUK BROKER RATINGS SUMMARY: Bernstein Upgrades easyJet And Ryanair
Read more(Sharecast News) - Life science research tools company Abcam reported a 10.8% increase in total revenue increased 10.8% on a reported basis and 8.3% on a constant exchange rate basis in its interim results on Monday, to ?138.2m.
Read moreUK WINNERS & LOSERS SUMMARY: Oil Stocks Sink As Brent Price Collapses
Read moreABCAM Profit Down In First Half; Expects Coronavirus To Hurt Revenue
Read more(Sharecast News) - Life sciences group Abcam extended its assay and labelling capabilities on Wednesday with the acquisition of Marker Gene Technologies for an undisclosed sum.
Read moreAbcam Buys US's Marker Gene Technologies, Issues GBP600,000 In Shares
Read moreUK Earnings, Trading Statements Calendar - Next 7 Days
Read moreAbcam Buys Applied StemCell Gene Editing Platform, Oncology Portfolio
Read moreDIRECTOR DEALINGS: Abcam's Milner Secures Over GBP15 Million From Sale
Read more